Centres de données
Au fur et à mesure que la technologie évolue, le besoin de l'immobilier spécialisé qui abrite l'infrastructure qui exploite ces systèmes évolue aussi.
Thrive Fitness will open a new, 11,900-square-foot gym in the heart of Chamblee, Georgia. Steve Hanna, Vice President at Cresa Global Inc., represented Thrive in this transaction.
Jim Underhill arguing that people are not going back—at least, not to the office life we had, with hundreds or thousands of employees showing up at the same building every day, often to be squeezed into a densely packed, open-plan office. “Call it a de-consolidation of space, rather than having everyone come into one massive office in the cities, though they will remain the hub,” he told Quartz.
As you continue to assess the impacts of COVID-19 on your business and workforce, Cresa can help you reinvent and reposition your business.
The COVID-19 pandemic has resulted in the largest global work-from-home experiment in modern history, with the benefits of flexible working increasingly being recognised globally. However, despite widespread speculation, the end of the office is not in sight.
While some companies prepare for the return to office, others are opting to incorporate remote work into their long-term workplace strategies. For these occupiers, it will be important to reevaluate your space utilization and — if it proves cost-effective — shed what you no longer need.
Martenson, Hasbrouck & Simon recently completed its move to a three-story build-to-suit office at 2573 Apple Valley Road in Brookhaven, Georgia. The firm previously had its Atlanta offices at 3379 Peachtree Road in the city's Buckhead financial district.
COVID-19 has prompted the most notable workplace transformation of our time. As companies rethink how and where they work, HR departments are at the center of this evolution, crafting policies and developing guidance to keep their workforce healthy, productive and supported.
On this episode Blake welcomes Greg Schiffman, Chief Financial Officer for Absci, the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. Greg discusses his career journey, the exciting growth from startup to IPO, and how SW Washington and Portland are positioned well to become a biotech hub.